Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parental Distress as a Predictor of Treatment Adherence in Pediatric Recurrent Medulloblastoma: A Prospective Longitudinal Cohort Study

NCT07660458 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07660458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07660458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parental Distress as a Predictor of Treatment Adherence in Pediatric Recurrent Medulloblastoma: A Prospective Longitudinal Cohort Study
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Withdrawn
Start date
June 1, 2025
Completion date
July 30, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medulloblastoma, recurrent medulloblastoma